Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Feb 29;10(3):97-100.
doi: 10.1016/j.aace.2024.02.008. eCollection 2024 May-Jun.

A Case of Primary Hyperparathyroidism Secondary to Parathyroid Adenoma in a Pediatric Patient

Affiliations
Case Reports

A Case of Primary Hyperparathyroidism Secondary to Parathyroid Adenoma in a Pediatric Patient

Gannon J Ray et al. AACE Clin Case Rep. .

Abstract

Background/objective: Although common in adults, primary hyperparathyroidism (PHPT) is a rare condition in children with the most common etiology being solitary parathyroid adenoma (PTA). The typical presentation is symptomatic hypercalcemia. Management of PHTP secondary to PTA requires excision of the adenoma.

Case report: A 13-year-old adolescent boy presented because of orbital cellulitis and was noted to have hypercalcemia. Despite this, the patient was curiously asymptomatic. Further investigations yielded an elevated parathyroid hormone (PTH) level and a normal urine calcium-to-creatinine ratio making the most likely cause of hypercalcemia PHTP secondary to PTA. Imaging demonstrated PTA. The patient underwent parathyroidectomy with the pathology demonstrating PTA. Postoperatively, the PTH levels were undetectable; hence, the patient was treated with calcitriol and calcium supplementation for 1 month and 4 months, respectively. Genetic work-up for multiple endocrine neoplasia 1 and rearranged during transfection mutations was negative.

Discussion: Solitary PTA is the most common cause of PHPT. Adenomas are mostly sporadic or may be a manifestation of an inheritable syndrome, such as multiple endocrine neoplasia. Although symptomatic disease is more common in children, our patient denied any hypercalcemia symptoms. The distinguishing biochemical feature of PHPT because of PTA is high or inappropriately normal PTH level in the context of high-normal or elevated serum calcium levels. Urinary calcium excretion is usually normal or high. PTAs are localized by ultrasound and Tc-99m-Sestamibi scintigraphy. Management includes parathyroidectomy and monitoring for postoperative hypocalcemia.

Conclusion: In a child or adolescent presenting with hypercalcemia and elevated PTH levels, it is important to consider PHPT secondary to PTA, because an early diagnosis will aid in preventing complications from hypercalcemia.

Keywords: hypercalcemia; parathyroid adenoma; primary hyperparathyroidism.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1
Parathyroid or thyroid ultrasonography demonstrates a 0.9 × 0.4 × 0.6 cm isoechoic nodule inseparable from posterior or mid right thyroid lobe. No significant internal color flow.
Fig 2
Fig 2
Parathyroid scintigraphy demonstrates radiotracer activity in both thyroid lobes within 15 minutes (left image) and with residual activity in the right thyroid lobe after 2 hour delay (right image).
Fig 3
Fig 3
Hematoxylin and eosin stain of parathyroid adenoma at ×200 magnification. Histopathologic findings include tissue that is densely cellular, richly vascularized, predominantly composed of chief cells with a few scattered oxyphil cells, and focally prominent anisonucleosis.

References

    1. Oh A., Lee Y., Yoo H.W., Choi J.H. Three pediatric patients with primary hyperparathyroidism caused by parathyroid adenoma. Ann Pediatr Endocrinol Metab. 2022;27(2):142–147. doi: 10.6065/apem.2142006.003. - DOI - PMC - PubMed
    1. Çetin S.K., Şıklar Z., Aycan Z., et al. Clinical profile of parathyroid adenoma in children and adolescents: a single-center experience. Turk Arch Pediatr. 2023;58(1):56–61. doi: 10.5152/TurkArchPediatr.2022.22180. - DOI - PMC - PubMed
    1. Sarafoglou K., Hoffmann G.F., Roth K.S. 2nd ed. McGraw Hill Professional; 2012. Pediatric Endocrinology and Inborn Errors of Metabolism; pp. 644–646.
    1. Bilezikian J.P., Bandeira L., Khan A., Cusano N.E. Hyperparathyroidism. Lancet. 2018;391(10116):168–178. doi: 10.1016/S0140-6736(17)31430-7. - DOI - PubMed
    1. Minisola S., Arnold A., Belaya Z., et al. Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism. J Bone Miner Res. 2022;37(11):2315–2329. doi: 10.1002/jbmr.4665. - DOI - PMC - PubMed

Publication types

LinkOut - more resources